Skip to content
10-Q

Quarterly Report

Aligos Therapeutics, Inc. ALGS

0001193125-25-268203

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 10.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.72M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.26M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$60.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$62.34M
Short Term Investments Q3 2025 · Sep 30, 2025 $57.15M
Short Term Investments Q3 2025 · Dec 31, 2024 $19.94M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $41.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $37M
Stockholders Equity Q3 2025 · Sep 30, 2025 $71.83M
Stockholders Equity Q3 2025 · Jun 30, 2025 $101.87M
Stockholders Equity Q3 2025 · Mar 31, 2025 $116.45M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$28.97M
Stockholders Equity Q3 2025 · Sep 30, 2024 $50.1M
Stockholders Equity Q3 2025 · Jun 30, 2024 $67.23M
Stockholders Equity Q3 2025 · Mar 31, 2024 $59.8M
Stockholders Equity Q3 2025 · Dec 31, 2023 $92.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $21.99M
Current Liabilities Q3 2025 · Dec 31, 2024 $21.74M
Total Liabilities Q3 2025 · Sep 30, 2025 $37.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $99.07M
Current Assets Q3 2025 · Sep 30, 2025 $103.44M
Current Assets Q3 2025 · Dec 31, 2024 $62.14M
Total Assets Q3 2025 · Sep 30, 2025 $109.76M
Total Assets Q3 2025 · Dec 31, 2024 $70.09M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.44
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.07
Eps Diluted Q3 2025 · Sep 30, 2024 −$7.84
Eps Basic Q3 2025 · Sep 30, 2025 −$3.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.44
Eps Basic Q3 2025 · Sep 30, 2024 −$3.07
Eps Basic Q3 2025 · Sep 30, 2024 −$7.84
Sga Expense Q3 2025 · Sep 30, 2025 $5.17M
Sga Expense Q3 2025 · Sep 30, 2025 $15.77M
Sga Expense Q3 2025 · Sep 30, 2024 $4.63M
Sga Expense Q3 2025 · Sep 30, 2024 $17.67M
Rd Expense Q3 2025 · Sep 30, 2025 $23.94M
Rd Expense Q3 2025 · Sep 30, 2025 $52.42M
Rd Expense Q3 2025 · Sep 30, 2024 $16.77M
Rd Expense Q3 2025 · Sep 30, 2024 $54.24M
Net Income Q3 2025 · Sep 30, 2025 −$31.54M
Net Income Q3 2025 · Sep 30, 2025 −$4.31M
Net Income Q3 2025 · Jun 30, 2025 −$15.86M
Net Income Q3 2025 · Mar 31, 2025 $43.09M
Net Income Q3 2025 · Sep 30, 2024 −$19.26M
Net Income Q3 2025 · Sep 30, 2024 −$49.06M
Net Income Q3 2025 · Jun 30, 2024 $5.06M
Net Income Q3 2025 · Mar 31, 2024 −$34.86M
Operating Income Q3 2025 · Sep 30, 2025 −$28.36M
Operating Income Q3 2025 · Sep 30, 2025 −$66.17M
Operating Income Q3 2025 · Sep 30, 2024 −$20.13M
Operating Income Q3 2025 · Sep 30, 2024 −$68.59M
Revenue Q3 2025 · Sep 30, 2025 $741K
Revenue Q3 2025 · Sep 30, 2025 $2.02M
Revenue Q3 2025 · Sep 30, 2024 $1.25M
Revenue Q3 2025 · Sep 30, 2024 $3.01M